Robert Bazemore
Board Member
Akari Therapeutics Plc (AKTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Akari Therapeutics Plc publishes a filing, an earnings call transcript or a press release.
Get AKTX alertsAbout Robert Bazemore
Robert Bazemore is recorded as Board Member at Akari Therapeutics Plc (AKTX) since September 17, 2024. Akari Therapeutics Plc reported in an 8-K filed September 18, 2024 that Robert Bazemore was appointed director of the Board, effective September 17, 2024. Akari Therapeutics Plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Akari Therapeutics Plc includes Abizer Gaslightwala (CEO and Board Member), Samir R. Patel (CEO), Samir R. Patel, M.D. (CEO) and 6 others.
“On September 13, 2024, the board of directors (the “Board”) of Akari Therapeutics, Plc (“Akari”) approved the expansion of the Board from five directors to six directors and the appointment of Robert Bazemore to serve as a director of the Board, effective as of September 17, 2024 (the “Effective Date”).”
Affiliation history
-
Current
2024-09-17–present
Company network
Leadership on record at Akari Therapeutics Plc
- Abizer Gaslightwala CEO, Board Member
- Samir R. Patel CEO
- Samir R. Patel, M.D. CEO
- Hoyoung Huh Chairman, Board Member
- Kameel Farag CFO
- Samir Patel CFO
- Torsten Hombeck CFO
- James Neal Board Member
- Sandip Patel Board Member